By Hannah Yemisi
A new Public-Private Partnership (PPP) has been established between the Federal Government of Nigeria and MedipoolNG Nigeria Limited to create a national Group Purchasing Organization aimed at lowering the cost of essential medicines and improving healthcare access.
The agreement was executed between the Federal Ministry of Health and Social Welfare and MedipoolNG Nigeria Limited as part of broader health sector reforms under the Presidential Initiative to Unlock the Healthcare Value Chain.
The concession agreement formalising the partnership was signed on February 16, 2026, establishing a procurement platform designed to aggregate demand for pharmaceuticals and medical supplies across the healthcare system.
Aluko & Oyebode served as legal advisers to the private partner in the transaction.
DECISION HIGHLIGHT
The Federal Government has adopted a centralised medicine procurement model through a Public-Private Partnership structure to address rising drug prices and supply inefficiencies in the healthcare sector.
The Group Purchasing Organization model is designed to consolidate demand for pharmaceuticals and medical products in order to negotiate better pricing and improve supply chain efficiency.
The partnership operates within the legal framework of the Infrastructure Concession Regulatory Commission Act governing public infrastructure concessions in Nigeria.
DECISION MEMO
Nigeria’s healthcare system has long struggled with high pharmaceutical costs, fragmented procurement processes and inconsistent supply chains.
Hospitals, clinics and government health facilities frequently procure medicines independently, often paying significantly different prices for identical products.
This fragmented purchasing structure weakens bargaining power and contributes to high medicine costs across the healthcare system.
The newly established Group Purchasing Organization seeks to address these structural inefficiencies.
Group Purchasing Organizations are widely used in global healthcare systems to consolidate procurement demand across hospitals and healthcare providers.
By aggregating orders for pharmaceuticals and medical equipment, these organisations negotiate bulk purchasing agreements with manufacturers and distributors.
Such arrangements can significantly reduce procurement costs while improving supply reliability.
Under the Nigerian arrangement, MedipoolNG Nigeria Limited will operate the purchasing platform in partnership with the Federal Ministry of Health and Social Welfare.
The initiative aligns with the Presidential Initiative to Unlock the Healthcare Value Chain, a broader government strategy aimed at strengthening domestic healthcare infrastructure and improving access to essential medical products.
Beyond cost reductions, the programme is expected to expand access to medicines across the country’s healthcare system.
Centralised procurement could also enhance transparency within pharmaceutical supply chains, reducing price disparities between healthcare institutions.
The legal framework governing the partnership was structured as a concession under the Infrastructure Concession Regulatory Commission Act.
The concession model allows private sector participation in the delivery of public sector infrastructure and services while maintaining government oversight.
Aluko & Oyebode advised MedipoolNG Nigeria Limited throughout the concession process.
The legal advisory mandate included the review, negotiation and execution of the concession agreement governing the partnership.
Oghogho Makinde and Cephas Caleb, Partners at Aluko & Oyebode, led the legal advisory team.
Makinde and Caleb were supported by Senior Associate Tega Abu, alongside Associates Aaron Alasa and Badrudeen Lawal.
The transaction reflects the increasing use of Public-Private Partnership structures in Nigeria’s healthcare sector, where government institutions seek private sector expertise to improve operational efficiency and financing capacity.
If implemented effectively, the Group Purchasing Organization could become a central component of Nigeria’s healthcare procurement system.
DATA BOX
Project Structure: Public-Private Partnership
Government Partner: Federal Ministry of Health and Social Welfare
Private Partner: MedipoolNG Nigeria Limited
Legal Framework: Infrastructure Concession Regulatory Commission Act
Concession Agreement Signed: February 16, 2026
Policy Initiative: Presidential Initiative to Unlock the Healthcare Value Chain
Legal Advisers: Aluko & Oyebode
Advisory Team Lead:
Oghogho Makinde
Cephas Caleb
Supporting Legal Team:
Tega Abu
Aaron Alasa
Badrudeen Lawal
Operational Model: Group Purchasing Organization
Primary Objective:
Reduce medicine procurement costs
Improve national access to pharmaceuticals
WHO WINS / WHO LOSES
Winners
Healthcare providers may gain access to lower-cost pharmaceuticals through consolidated procurement.
Patients could benefit from improved availability and affordability of essential medicines.
Pharmaceutical manufacturers may gain access to larger consolidated purchasing contracts.
Losers
Fragmented procurement intermediaries may lose market relevance if centralised purchasing becomes dominant.
Suppliers unable to compete in bulk procurement tenders may face reduced market access.
POLICY SIGNALS
The partnership signals increasing reliance on Public-Private Partnerships within Nigeria’s healthcare reform strategy.
It also reflects a policy shift toward centralised procurement mechanisms designed to address systemic inefficiencies within the pharmaceutical supply chain.
INVESTOR SIGNAL
The project indicates growing opportunities for private sector participation in Nigeria’s healthcare infrastructure and supply chain management.
Investors may view healthcare procurement platforms and pharmaceutical distribution networks as emerging areas of commercial opportunity.
RISK RADAR
Three structural risks remain visible.
First is implementation risk, particularly in integrating procurement systems across Nigeria’s complex healthcare network.
Second is supply chain governance risk, as centralised procurement requires strong regulatory oversight to prevent market distortions.
Third is operational sustainability risk, where the long-term effectiveness of the purchasing platform will depend on consistent participation by healthcare providers.
The partnership therefore represents both a healthcare reform initiative and a broader experiment in using public-private collaboration to address structural inefficiencies in Nigeria’s medical supply chain.
Discover more from StakeBridge Media
Subscribe to get the latest posts sent to your email.